Drug Profile


Latest Information Update: 01 Jul 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Alkaloids; Antirheumatics; Herbal medicines
  • Mechanism of Action Calcium channel antagonists; Immunosuppressants; Potassium channel antagonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Arrhythmias; Inflammation; Rheumatic disorders; Rheumatoid arthritis; Transplant rejection

Most Recent Events

  • 27 Aug 2001 A study in patients with rheumatoid arthritis has been added to the Rheumatic Disease therapeutic trials section
  • 15 Sep 1998 Investigation in Rheumatoid arthritis in China (PO)
  • 08 Sep 1998 Investigation in Arrhythmias in China (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top